dexchlorpheniramine


Also found in: Wikipedia.

dexchlorpheniramine

 [deks″klor-fen-ir´ah-mēn]
the dextrorotatory isomer of chlorpheniramine, having similar actions and uses as an antihistamine, but having approximately twice the activity by weight; used in the form of the maleate salt.

dexchlorpheniramine

/dex·chlor·phen·ir·a·mine/ (-klor-fen-ēr´ah-mēn) the dextrorotatory isomer of chlorpheniramine, used as the maleate salt as an antihistamine.

dexchlorpheniramine

the dextrorotatory form of chlorpheniramine used as an antihistaminic in the form of the maleate salt.
References in periodicals archive ?
The current recommendation is to discontinue the infusion and not retreat the patient; however, this recommendation is being reviewed and pre-treatment with hydrocortisone and dexchlorpheniramine appears to prevent these reactions.
24 mg/kg ideal body weight once daily, and 19 children received first-generation dexchlorpheniramine syrup at 0.
Dexchlorpheniramine provides the same effective relief with about one-half of the antihistamine ingredient.
Investigation of the reasons for failing to identify other target drugs gave the following results: drugs present but below the detection limit (n = 2), erythromycin and acetaminophen; drugs not yet established in the library entries at the time of analysis (n = 5), phenolphthalein, metoclopramide (2 occasions), cannabinoids, and dexchlorpheniramine.
Supply of drugs iron sucrose (DOE), fentanyl (DOE) patches, levetiracetam (DOE), epirubicin (DOE), dexchlorpheniramine (DOE), irinotecan (DOE) and doxorubicin (DOE) for all service organizations Osakidetza.
Tenders are invited for Supply of Dexchlorpheniramine Maleate Syrup 2 mg/5ml 30 ml Bottle.
These two recently launched Tanafed suspension line extensions have been formulated using dexchlorpheniramine, a single-isomer of chlorpheniramine that provides the same effective relief with about one-half of the antihistamine ingredient.
31 /PRNewswire/ -- Arcturus Pharmaceutical Corporation announced the start of a Phase IB/II clinical trial with a novel topical formulation of dexchlorpheniramine for the treatment of pruritus (itch) associated with skin disorders.
The Company's first application of this technology is the formulation of topical dexchlorpheniramine for the treatment of pruritus (itching).
The trials include a Phase I clinical study with a novel topical formulation of the antihistamine dexchlorpheniramine for the treatment of pruritis (itch), and two pilot clinical studies of an anti-inflammatory agent.
25 /PRNewswire/ -- Arcturus Pharmaceutical Corporation announced today that the company has started Phase I clinical studies with a novel topical formulation of the antihistamine dexchlorpheniramine for the treatment of pruritis (itch) associated with skin disorders such as contact and atopic dermatitis.